MORPHINE SULFATE 100 mg/1 (Morphine Sulfate TABLET, EXTENDED RELEASE) 100 mg/1

Morphine Sulfate 100 mg extended-release tablets provide long-lasting pain relief. This opioid analgesic is designed for around-the-clock management of moderate to severe pain.

Strength

100 mg/1

Pack Size

1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0406-8390-23)

Manufacturer / TM Owner

SpecGx LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Morphine Sulfate is primarily used for managing moderate to severe pain that requires continuous, extended relief. It is often prescribed for chronic pain conditions where immediate-release opioids are insufficient. Patients may ask, 'What is Morphine Sulfate used for?' It is typically used in cases where pain management needs to be sustained over a longer period.

Side Effects

Morphine Sulfate may cause drowsiness, dizziness, constipation, and nausea. Some users experience itching or dry mouth. These effects can vary widely among individuals and may diminish with regular use.

Precautions & Warnings

Handle Morphine Sulfate with care, as it is a potent opioid. Store it securely to prevent misuse. Avoid activities requiring alertness until you know how this medication affects you. Consult a healthcare provider before use if you have respiratory issues or a history of substance abuse.

Avoid Interactions

Morphine Sulfate can interact with alcohol, other opioids, and certain antidepressants. It may also interact with medications that affect liver enzymes, such as CYP3A4 inhibitors. Always inform your healthcare provider about all medications you are taking.

Frequently Asked Questions

Morphine Sulfate is used for managing moderate to severe pain that requires continuous, extended relief.

Morphine Sulfate extended-release tablets should be taken orally, typically once daily, as prescribed by a healthcare provider.

Common side effects include drowsiness, dizziness, constipation, and nausea.

Morphine Sulfate can interact with various medications, including alcohol and other opioids. Always consult a healthcare provider before combining medications.

Long-term use of Morphine Sulfate should be monitored by a healthcare provider to manage potential side effects and dependence.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.